Admission Date:  [**2119-9-16**]              Discharge Date:   [**2119-9-27**]  Date of Birth:  [**2036-7-6**]             Sex:   F  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 2610**] Chief Complaint: Respiratory Distress  Major Surgical or Invasive Procedure: NA   History of Present Illness: 83y/oF Spanish-speaking with a PMH of COPD on home 3L O2, DM2, diastolic CHF, admitted with dyspnea.
In the ED her vitals were 99.3 110 [**Numeric Identifier **] 15 100% 10L -> 95% on 4L, the pt was given Levaquin 750mg x1, Ceftriaxone 1gm x1, Tylenol 650mg PR, Prednisone 60mg PO xl, as well as neb treatments.
Multiple unsuccesful attempts were made to obtain an blood gas.
Past Medical History: -HTN -DM2 -CVA: bleeding aneurysm x 2, s/p clipping -CHF: diastolic ([**Hospital1 112**]: ef 75%) -COPD: FEV1 0.46, 27%; FVC 0.48, 20% -seizure d/o (further details unknown) -AS   Social History: Lives with daughter.
[**2119-9-15**] 09:55PM URINE  RBC-0 WBC-[**2-15**] BACTERIA-MANY YEAST-NONE EPI-0 [**2119-9-15**] 09:55PM URINE  BLOOD-NEG NITRITE-POS PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2119-9-15**] 09:55PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.016 [**2119-9-15**] 09:55PM URINE  GR HOLD-HOLD [**2119-9-15**] 09:55PM URINE  HOURS-RANDOM [**2119-9-15**] 10:01PM   GLUCOSE-141* LACTATE-2.0 NA+-141 K+-5.8* CL--92* TCO2-38* [**2119-9-15**] 10:15PM   PLT COUNT-237 [**2119-9-15**] 10:15PM   NEUTS-82.2* LYMPHS-10.5* MONOS-7.1 EOS-0.3 BASOS-0 [**2119-9-15**] 10:15PM   WBC-12.6*# RBC-3.22* HGB-7.1*# HCT-26.4* MCV-82 MCH-22.0*# MCHC-26.8*# RDW-16.4* [**2119-9-15**] 10:15PM   CK-MB-NotDone cTropnT-<0.01 [**2119-9-15**] 10:15PM   CK(CPK)-45 [**2119-9-15**] 10:15PM   estGFR-Using this [**2119-9-15**] 10:15PM   UREA N-21* CREAT-0.6 [**2119-9-16**] 09:21AM   PLT COUNT-187 [**2119-9-16**] 09:21AM   NEUTS-84.4* LYMPHS-9.5* MONOS-6.0 EOS-0.1 BASOS-0 [**2119-9-16**] 09:21AM   WBC-11.4* RBC-2.82* HGB-6.2* HCT-22.8* MCV-81* MCH-21.8* MCHC-26.9* RDW-16.4* [**2119-9-16**] 09:21AM   CALCIUM-8.3* PHOSPHATE-2.4* MAGNESIUM-2.0 [**2119-9-16**] 09:21AM   GLUCOSE-138* UREA N-22* CREAT-0.6 SODIUM-141 POTASSIUM-5.4* CHLORIDE-99 TOTAL CO2-40* ANION GAP-7* [**2119-9-16**] 03:50PM   POTASSIUM-5.5* [**2119-9-16**] 05:38PM   TYPE-ART PO2-87 PCO2-86* PH-7.30* TOTAL CO2-44* BASE XS-12 INTUBATED-NOT INTUBA [**2119-9-16**] 07:04PM   K+-5.5* [**2119-9-16**] 07:04PM   TYPE-ART O2 FLOW-2 PO2-61* PCO2-81* PH-7.31* TOTAL CO2-43* BASE XS-10 INTUBATED-NOT INTUBA COMMENTS-NASAL [**Last Name (un) 154**]  Brief Hospital Course: # Dyspnea: The patient presented with worsening dyspnea and increased 02 requirement from 3L to 4L in the setting of a fever, and mild leukocytosis and productive cough of 1.5 weeks duration.
CXR with questioable retrocardiac infiltrate, without over signs of fluid overload and slightly decreased BNP from [**Month (only) 205**].
Upon admission to the floor, the patient was somulent and an ABG was noted to be 7.31/86/61 on 3L.
Imaging showed a progressive RLL infiltrate and possible LLL infiltrate.
Repeat ABG (upon arrival to the unit) was 7.31/81/61 on 3L.
A TTE was performed to assess the pt's aortic stenosis which showed mild symmetric left ventricular hypertrophy with preserved global and regional biventricular systolic function.
The patient will need monitoring of the vanc level and appropriate adjustment in dose.
A transfusion of two units of pRBC was performed with an increase in HCT (23 to 25).
# Hyperkalemia: Upon arrival the pt was found to have a K of 5.4 without EKG changes.
Continued Phenytoin but her dose was doubled as her phenytoin serum level was low.
Troponins were negative.
-Docusate Sodium 50 mg/5 mL Liquid Sig: Ten (10) mL PO BID (2 times a day).
-Bisacodyl 10 mg Suppository Sig: 1 PR QHS PRN -Ferrous Sulfate 325 mg PO DAILY -Pravastatin 20 mg Tablet Sig: Two (2) Tablet PO DAILY -Fluticasone 110 mcg/Actuation 4 Puff Inhalation [**Hospital1 **] -Ipratropium Bromide 0.02 % Solution Sig: 1 Q6H PRN -Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for -Nebulization Sig: One (1)  Inhalation Q6H (every 6 hours) as needed.
Docusate Sodium 50 mg/5 mL Liquid Sig: One (1)  PO BID (2 times a day).
Phenytoin Sodium Extended 100 mg Capsule Sig: Two (2) Capsule PO TID (3 times a day).
Piperacillin-Tazobactam-Dextrs 4.5 gram/100 mL Piggyback Sig: One (1)  Intravenous Q8H (every 8 hours) for 4 days: Day 1 on [**9-17**]; to complete 14 day course.
Polyethylene Glycol 3350 100 % Powder Sig: One (1)  PO DAILY (Daily) as needed for constipation.
